SymBiosis
Geraldine Schott, PhD, currently serves as an Associate at SymBiosis since June 2025, following a role as Senior Associate at pH Partners from January 2022 to June 2025. Prior experience includes working as a Life Sciences Specialist for the Department for International Trade (DIT) and as a Postdoctoral Researcher at The University of Texas Medical Branch, where Geraldine also completed a PhD in Biochemistry and Molecular Biology. Additional qualifications include a Bachelor's degree in Microbiology from the University of Houston-Downtown and an International Baccalaureate from Lycée Louis Pasteur in Strasbourg. Geraldine has held various academic and consulting positions, demonstrating a strong foundation in biological sciences and mentorship throughout an extensive educational and professional career.
This person is not in any teams
This person is not in any offices
SymBiosis
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments.